Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Central Standard Time Zone
| Friday, November 6, 2026 |
|---|
| 7:00am | Check-in and Breakfast in Exhibit Hall |
| 8:00am | Horizon CME App Overview |
| 8:05am | Welcome, Introductions, & CE Housekeeping |
| 8:10am | (01A) Evolution of Cancer Drug Therapy: Leveraging Biological Targets within Clinical Practice » Noor Alawad, PharmD – Hematology/Oncology Pharmacy Resident | University of Illinois Retzky College of Pharmacy | Chicago, IL |
| 9:10am | (02A) Hormone Replacement Therapy in Radiation Oncology » Emily Smith, MSN, WHNP-BC, CRNP – Radiation Oncology | Penn Medicine | Philadelphia, PA |
| 9:55am | Information About the Cancer Charities & Trivia For Charity Break |
| 10:00am | Break – Trivia for Charity in Exhibit Hall |
| 10:25am | (03A) Before the First Dose: Identifying and Managing DPD Deficiency in Fluoropyrimidine Therapy » Noor Naffakh, PharmD, MS, BCOP – Clinical Assistant Professor | Department of Pharmacy Practice | Hematology/Oncology Pharmacist | University of Illinois Hospital and Health Sciences System | Chicago, IL |
| 11:25am | (04A) Endocrinopathies Associated with Immune Checkpoint Inhibitor Therapies » Sandra Naaman, MD, PhD, FACP – Assistant Professor | Director of Onco-endocrinology & Cancer Survivorship | Department of Internal Medicine, Division of Hematology, Oncology & Cell Therapy | RUSH MD Anderson Cancer CenterChicago, IL |
| 12:10pm | Gather Lunch |
| 12:15pm | #1 Buffet Lunch & Non-CME/CE Presentation Sponsored by Astellas/Pfizer (PADCEV) -Bladder Cancer: Identifying the Right Patient, at the Right Time: A New Treatment Paradigm in Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility » Susan Utley, MSN, FNP-BC, AOCNP
#2 Buffet Lunch & Non-CME/CE Presentation Sponsored by Incyte (Niktimvo/Jakafi) » TBA |
| 1:00pm | After Lunch Dessert Break in Exhibit Hall |
| 1:15pm | (05A) Bridging the Gap in Neurofibromatosis Type 1-Plexiform Neurofibroma Care | This activity is supported by an educational grant from SpringWorks Therapeutics, Inc. and Alexion, AstraZeneca Rare Disease. » Lauren M. Garner, PharmD, BCPPS, CPP – Clinical Pharmacist Practitioner, Pediatric Oncology Clinic | Program Coordinator, PGY2 Pediatric-Focused Oncology Pharmacy Residency | University of North Carolina Medical Center | Chapel Hill, NC |
| 2:15pm | (06A) Understanding and Mitigating Financial Toxicity in Cancer Care » Laila Gharzai, MD – Radiation Oncologist | Northwestern Medicine | Chicago, IL |
| 3:00pm | Break – Refreshments in Exhibit Hall |
| 3:30pm | (07A) Pancreatic Cancer Care in Transition: What Oncology APPs Need to Know » Devalingam Mahalingam, MD – Associate Director of Clinical Research | Director, Developmental Therapeutics (DT) and DT Fellowship Program | Robert H. Lurie Comprehensive Cancer Center | Professor of Medicine, Division of Hematology/Oncology, Dept. of Medicine | Northwestern University Feinberg School of Medicine
(07B) Strategies for Sequencing Therapies in Patients with Diffuse Large B Cell Lymphoma (DLBCL) | A Focus on Bispecific Antibody or CAR-T Therapies » Parameswaran Venugopal, MD – Hematologist | Rush University | Chicago, IL |
| 4:15pm | Transition Break |
| 4:20pm | (08A) A Roadmap for Building an APP-Led Benign Hematology Clinic: An APP Panel Discussion » Moderator: Victoria Caulfield, MSN, APRN-FNP, AOCNP – Nurse Practitioner, Hem/Onc Lead APP | Northwestern Medical Group | Chicago, IL » Flesscia S. Mercer, APRN – Nurse Practitioner | OSF HealthCare | Peoria, IL » Jill Folkert, DNP, MBA, ACNP-BC, AOCNP, CGRA – Assistant Director, APP Services, Clinical Operations | Texas Oncology | Dallas, TX » Bukurije Alijoski, APRN – Nurse Practitioner | Northwestern Medical Group | Chicago, IL |
| 5:20pm | Network Reception |
| 6:30pm | Non-CME/CE Dinner Presentation Presented by TBA |
| Saturday, November 7, 2026 |
|---|
| 7:00am | Check-in & Exhibit Hall Open |
| 7:50am | Welcome, Introductions, & CE Housekeeping |
| 7:55am | (09A) Prehabilitation and Beyond: A Case-Based Approach to Rehabilitative Interventions for Cancer Survivors » Obada Obaisi, MD – Cancer Rehabilitation Medical Director | Rush University | Chicago, IL |
| 8:40am | Gather for Breakfast |
| 8:45am | #1 Buffet Breakfast & Non-CME/CE Presentation Sponsored by Pfizer Oncology: Learn About a Treatment Option for Patients With HR+/HER2+ mBC » TBA
#2 Buffet Breakfast & Non-CME/CE Presentation Sponsored by Pfizer » TBA |
| 9:30am | Transition Break |
| 9:35am | (10A) Psychological Oncology: Recognizing and Responding to Distress, Trauma, and Grief in Cancer Care » Sarah Rose Thilges, PhD – Associate Professor | Loyola University | Maywood, IL |
| 10:20am | Break – Refreshments in Exhibit Hall |
| 10:35am | (11A) Cancer-Therapy Associated Dermatologic Toxicities » Samantha Venkatesh, MD – Dermatologist | RUSH Medical Group | Chicago, IL |
| 11:20am | Gather Lunch |
| 11:25am | Buffet Lunch & Non-CME/CE Presentation Sponsored by PharmaEssentia BESREMi (ropeginterferon-alfa-2b)- Hematology → blood cancers (e.g., leukemia, lymphoma, myeloma) » TBA |
| 12:10pm | Transition Break |
| 12:15pm | (12A) Navigating Metastatic Brain Disease: A Case-Based Panel Discussion » Moderator: Alexis Larson, APRN, NP-C, OCN – Radiation Oncology Nurse Practitioner | Northwestern Memorial Hospital | Chicago, IL » Sean Sachdev, MD – Vice Chair of Education, Radiation Oncology | Associate Professor | Northwestern Medicine | Chicago, IL » Ditte Primdahl, MD – Neuro Oncologist | Northwestern Medicine | Chicago, IL » Karan S. Dixit, MD – Associate Professor of Neurology | Northwestern University Feinberg School of Medicine | Chicago, IL |
| 1:15pm | Adjourn |